Cancer, Cancer Treatment

Tuesday October 14, 2008 (foodconsumer.org) — In the National Breast Cancer Awareness Month, the campaign organizers and sponsors want as many women as possible to know the risk of breast cancer in hopes that more women or even men may go to receive regular screenings for breast cancer.

The risk is not the same to everyone. That is why you are not going to do screening at a young age. But how many people really know they are in the low risk group or high risk group remains questionable.

Read the rest of this entry »

WEDNESDAY, Nov. 5 — There aren’t a lot of treatment options for older women with flagging libidos, but a new study suggests that a testosterone patch may significantly improve the number of satisfying sexual episodes that women experience.

However, the increased sexual satisfaction doesn’t come without side effects, such as unwanted hair. Of more concern is a possible increase in the risk of breast cancer in women taking the male hormone, although the study’s authors think this finding was probably a chance occurrence.

Read the rest of this entry »

Menopause is a critical stage of womens life as it brings different kind of medical complications and the hormonal changes in the body. The sudden changes in the body make most of the women vulnerable to disease like osteoporosis. Osteoporosis is a disease, which decreases the density of the bone mass. In order to provide some relief to the women suffering from osteoporosis, an effective medication is available in the form of Evista. Evista is a medication which is mostly used to prevent osteoporosis in post menopausal women and it works by affecting the bone formation cycle and breakdown in the body. It also reduces the risk of invasive breast cancer in post menopausal women. To get relief from post menopausal problem and disease such as osteoporosis, one can buy Evista and live a healthy life. Evista, a FDA approved medication is considered as a safe and trusted drug for the treatment of osteoporosis and is presently taken by almost half a million women in the U.S for the treatment of osteoporosis and thinning of bone. Evista is a beneficial in numerous ways to women who have reached menopause. To have best effect of Evista, supplemental calcium or vitamin D should be added to the diet if daily intake is inadequate. Researchers have proved that Evista lowers the rate of breast cancer in women. It works like the Estrogen hormone and is effective in two ways. Buy Evista to reduce bone loss and also to increase the bone density. Moreover, unlike Estrogen, Evista does not affect the uterus and breasts of the women, thus, it does not increase the risk of breast and uterus cancer.
Read the rest of this entry »

Breast cancer patients are risking their lives by failing to take the tamoxifen they are prescribed, according to a new study published in the British Journal of Cancer.

Half of the women failed to finish a five year course of the drug and one in five regularly forget to take a tablet.

Experts already know that taking tamoxifen for five years increases survival chances and the new research reveals that women who miss at least one tablet every five days have a 10 per cent greater risk of dying.

NEW YORK (Reuters Health) - Strategies introduced in the late 1980s for protecting fertility in patients undergoing cancer treatment may have indeed helped boost reproduction rates modestly among survivors of certain types of cancer, new research from Norway suggests.

However, overall, female cancer survivors remain about half as likely as women who had never been diagnosed with the disease to have a child within the 10 years following their diagnosis, the researchers found. For male cancer survivors, reproduction rates were about 30 percent lower than among their healthy peers.

Read the rest of this entry »

Testosterone, the male sex hormone, boosts sexual desire and activities in postmenopausal women, according to a recent study. But a small review published earlier said the effect of the male hormone therapy on the risk of breast cancer remains uncertain.

Off-label use of testosterone is allowed in the United States although the FDA has not approved this treatment for low sexual function or hypoactive sexual desire disorder particularly in postmenopausal women who experience surgery induced menopause.

Read the rest of this entry »

The trial of Procter & Gamble’s Intrinsa testosterone patches for women was sponsored by Procter & Gamble and the treatment was indicated for hypoactive sexual desire disorder (HSDD).

“HSDD is characterized as a lack or absence of sexual fantasies and desire for sexual activity for some period of time”, Wikipedia states. An estimated 26.7% among premenopausal women and 52.4% among naturally menopausal women had the condition, according to another study published in the July 2008 issue of Archives of Internal Medicine.

Read the rest of this entry »

Breast cancer patients are risking their lives by failing to take the tamoxifen they are prescribed, according to a new study published in the British Journal of Cancer.

Half of the women failed to finish a five year course of the drug and one in five regularly forget to take a tablet.

Experts already know that taking tamoxifen for five years increases survival chances and the new research reveals that women who miss at least one tablet every five days have a 10 per cent greater risk of dying.